ARS Pharmaceuticals, Inc.
General ticker "SPRY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.1B (TTM average)
ARS Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -19.0%.
Estimated limits based on current volatility of 2.4%: low 9.61$, high 10.09$
Factors to consider:
- Total employees count: 90 as of 2021
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.04$, 13.09$]
- 2026-12-31 to 2027-12-31 estimated range: [4.08$, 10.86$]
Financial Metrics affecting the SPRY estimates:
- Negative: with PPE of -6.3 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: 19.24 < Shareholder equity ratio, % of 34.87 <= 42.59
- Positive: Investing cash flow per share per price, % of 5.21 > -0.60
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Net income
Short-term SPRY quotes
Long-term SPRY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.03MM | $89.15MM | $84.28MM |
| Operating Expenses | $67.55MM | $92.23MM | $263.73MM |
| Operating Income | $-67.52MM | $-3.08MM | $-179.45MM |
| Non-Operating Income | $13.15MM | $11.37MM | $8.07MM |
| R&D Expense | $20.27MM | $19.58MM | $13.18MM |
| Income(Loss) | $-54.37MM | $8.29MM | $-171.38MM |
| Taxes | $0.00MM | $0.29MM | $-0.08MM |
| Net Income(Loss)* | $-54.37MM | $8.00MM | $-171.30MM |
| Stockholders Equity | $230.76MM | $256.80MM | $114.26MM |
| Inventory | $0.00MM | $5.21MM | $8.37MM |
| Assets | $233.19MM | $351.15MM | $327.65MM |
| Operating Cash Flow | $-59.27MM | $13.55MM | $-170.87MM |
| Capital expenditure | $0.17MM | $0.56MM | $0.34MM |
| Investing Cash Flow | $-87.18MM | $-106.10MM | $56.77MM |
| Financing Cash Flow | $6.90MM | $72.40MM | $104.60MM |
| Earnings Per Share** | $-0.57 | $0.08 | $-1.74 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.